RxDoctor Payments Data

Jill Karpel

Pulmonary Disease · Great Neck, NYNPI 1225107592

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,655 of the $4,348 with a category attached, or 61.0%. Boehringer Ingelheim International GmbH accounts for 61.0% of it on its own, with 19 other manufacturers making up the rest.

$4,348in general payments, 2019–2025

Across 92 payments — averaging $47.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$3K
  • GSK$501
  • Novartis$188
  • Boehringer Ingelheim$152
  • Genentech USA, Inc.$150
  • Grifols USA, LLC$98
  • plus $605 from 14 others

What the payments were for

  • Speaking & faculty fees$2,65561%
  • Food & beverage$1,69439%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,348 in reported general payments places this provider in the 70th percentile of 1,115 pulmonary disease providers in New York.

See all pulmonary disease providers in New York →

Other pulmonary disease in Great Neck

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →